The global electronic Clinical Outcome Assessment (eCOA) market is expected to reach USD 4,744,628.72 thousand by 2031 from USD 1,474,897.61 thousand in 2023, growing at a CAGR of 15.8% during the forecast period of 2024 to 2031.
Market Segmentation
Global Electronic Clinical Outcome Assessment (eCOA) Market, By Type (Clinician Reported Outcome Assessment (CLINRO), Patient Reported Outcome Assessment (PRO), Observer Reported Outcome Assessment (OBSRO), and Performance Outcome Assessment (PERFO)), Modality (Site-Based Solutions, Web Solutions, and Handheld), End User (Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Firms, Medical Device Companies, Hospitals/Healthcare Providers, Consulting Service Companies, Academic & Research Institutes, and Others), Delivery Mode (Cloud-Based and Web-Hosted), Country (U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, Switzerland, Netherlands, Belgium, Turkey, Russia, Rest of Europe, China, Japan, Australia, South Korea, India, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, U.A.E., Israel, Saudi Arabia, Egypt, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2031.
Overview of the Global Electronic Clinical Outcome Assessment (eCOA) Market Dynamics
- Driver
- Growing acceptance of eCOA among clinical research professionals
- Restraint
- Implementation of 'Bring Your Own Device' (BYOD) technology in clinical trials
- Opportunity
- Growing adoption of cloud-based services
Market Players
Some of the major market players operating in the global electronic Clinical Outcome Assessment (eCOA) market are:
- Medidata (A Subsidiary of Dassault Systemes)
- Clario
- IQVIA Inc
- Signant Health
- ArisGlobal
- TransPerfect Life Sciences
- WCG Clinical.
- Kayentis
- Castor
- Suvoda LLC
- Vitalograph
- Medable Inc.
- Cloudbyz
- YPrime LLC.
- Merative
- EvidentIQ
- Climedo Health GmbH
- RAYLYTIC GmbH
- Clinical Ink
- Assistek
- Pattern Health Technologies, Inc.
- clincapture
- Crucial Data Solutions
TABLE OF CONTENTS
1 INTRODUCTION 44
- 1.1 OBJECTIVES OF THE STUDY 44
- 1.2 MARKET DEFINITION 44
- 1.3 OVERVIEW OF THE GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET 44
- 1.4 LIMITATIONS 45
- 1.5 MARKETS COVERED 46
2 MARKET SEGMENTATION 48
- 2.1 MARKETS COVERED 48
- 2.2 GEOGRAPHICAL SCOPE 49
- 2.3 YEARS CONSIDERED FOR THE STUDY 50
- 2.4 CURRENCY AND PRICING 50
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL 51
- 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54
- 2.7 DBMR MARKET POSITION GRID 55
- 2.8 VENDOR SHARE ANALYSIS 57
- 2.9 MULTIVARIATE MODELLING 58
- 2.10 TYPE TIMELINE CURVE 59
- 2.11 MARKET APPLICATION COVERAGE GRID 60
- 2.12 SECONDARY SOURCES 61
- 2.13 ASSUMPTIONS 61
3 EXECUTIVE SUMMARY 62
4 PREMIUM INSIGHTS 65
- 4.1 PESTEL ANALYSIS 66
- 4.2 PORTER'S FIVE FORCES ANALYSIS 67
5 REGULATORY FRAMEWORK 68
6 MARKET OVERVIEW 70
- 6.1 DRIVERS 72
- 6.1.1 GROWING ACCEPTANCE OF ECOA AMONG CLINICAL RESEARCH PROFESSIONALS 72
- 6.1.2 PARADIGM SHIFT TOWARDS ELECTRONIC DATA CAPTURING FROM PAPER-BASED PROCEDURES 73
- 6.1.3 GOVERNMENT INITIATIVES ABOUT THE ADOPTION OF ECLINICAL PLATFORMS 74
- 6.2 RESTRAINTS 75
- 6.2.1 IMPLEMENTATION OF 'BRING YOUR OWN DEVICE' (BYOD) TECHNOLOGY IN CLINICAL TRIALS 75
- 6.2.2 LACK OF PROPER HEALTHCARE IT INFRASTRUCTURE IN DEVELOPING COUNTRIES 76
- 6.3 OPPORTUNITIES 76
- 6.3.1 GROWING ADOPTION OF CLOUD-BASED SERVICES 76
- 6.3.2 RISING NUMBER OF RESEARCH STUDIES FOCUSING ON CLINICAL OUTCOME ASSESSMENTS 77
- 6.4 CHALLENGES 78
- 6.4.1 DIFFICULTIES ASSOCIATED WITH TRAINING OF RESPONDENTS TO FILL ELECTRONIC QUESTIONNAIRES 78
- 6.4.2 STREAMLINING OF ECOA SERVICES 78
7 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY TYPE 80
- 7.1 OVERVIEW 81
- 7.2 CLINICIAN REPORTED OUTCOME ASSESSMENT (CLINRO) 82
- 7.3 PATIENT REPORTED OUTCOME ASSESSMENT (PRO) 83
- 7.4 OBSERVER REPORTED OUTCOME ASSESSMENT (OBSRO) 83
- 7.5 PERFORMANCE OUTCOME ASSESSMENT (PERFO) 84
8 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY MODALITY 85
- 8.1 OVERVIEW 86
- 8.2 SITE-BASED SOLUTIONS 87
- 8.3 WEB SOLUTIONS 88
- 8.4 HANDHELD 88
- 8.4.1 BRING-YOUR-OWN-DEVICE (BYOD) 89
- 8.4.2 PROVISIONED DEVICES 89
9 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY END USER 90
- 9.1 OVERVIEW 91
- 9.2 CONTRACT RESEARCH ORGANIZATIONS (CROS) 92
- 9.2.1 SITE-BASED SOLUTIONS 93
- 9.2.2 WEB SOLUTIONS 93
- 9.2.3 HANDHELD 93
- 9.3 PHARMACEUTICAL AND BIOTECHNOLOGY FIRMS 93
- 9.3.1 SITE-BASED SOLUTIONS 94
- 9.3.2 WEB SOLUTIONS 94
- 9.3.3 HANDHELD 94
- 9.4 MEDICAL DEVICE COMPANIES 94
- 9.4.1 SITE-BASED SOLUTIONS 95
- 9.4.2 WEB SOLUTIONS 95
- 9.4.3 HANDHELD 95
- 9.5 HOSPITALS/HEALTHCARE PROVIDERS 95
- 9.5.1 SITE-BASED SOLUTIONS 96
- 9.5.2 WEB SOLUTIONS 96
- 9.5.3 HANDHELD 96
- 9.6 CONSULTING SERVICE COMPANIES 96
- 9.6.1 SITE-BASED SOLUTIONS 97
- 9.6.2 WEB SOLUTIONS 97
- 9.6.3 HANDHELD 97
- 9.7 ACADEMIC & RESEARCH INSTITUTES 97
- 9.7.1 SITE-BASED SOLUTIONS 98
- 9.7.2 WEB SOLUTIONS 98
- 9.7.3 HANDHELD 98
- 9.8 OTHERS 98
- 9.8.1 SITE-BASED SOLUTIONS 99
- 9.8.2 WEB SOLUTIONS 99
- 9.8.3 HANDHELD 99
10 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY DELIVERY MODE 100
- 10.1 OVERVIEW 101
- 10.2 CLOUD-BASED 102
- 10.3 WEB-HOSTED 102
11 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET, BY REGION 103
- 11.1 OVERVIEW 104
- 11.2 NORTH AMERICA 107
- 11.2.1 U.S. 112
- 11.2.2 CANADA 117
- 11.2.3 MEXICO 121
- 11.3 EUROPE 126
- 11.3.1 GERMANY 131
- 11.3.2 U.K. 135
- 11.3.3 FRANCE 139
- 11.3.4 ITALY 143
- 11.3.5 RUSSIA 147
- 11.3.6 SPAIN 151
- 11.3.7 POLAND 155
- 11.3.8 TURKEY 159
- 11.3.9 NETHERLANDS 163
- 11.3.10 BELGIUM 167
- 11.3.11 SWITZERLAND 171
- 11.3.12 SWEDEN 175
- 11.3.13 DENMARK 179
- 11.3.14 FINLAND 183
- 11.3.15 NORWAY 187
- 11.3.16 REST OF EUROPE 191
- 11.4 ASIA-PACIFIC 192
- 11.4.1 CHINA 197
- 11.4.2 JAPAN 201
- 11.4.3 SOUTH KOREA 205
- 11.4.4 INDIA 209
- 11.4.5 AUSTRALIA 213
- 11.4.6 SINGAPORE 217
- 11.4.7 THAILAND 221
- 11.4.8 MALAYSIA 225
- 11.4.9 INDONESIA 229
- 11.4.10 PHILIPPINES 233
- 11.4.11 NEW ZEALAND 237
- 11.4.12 VIETNAM 241
- 11.4.13 TAIWAN 245
- 11.4.14 REST OF ASIA-PACIFIC 249
- 11.5 SOUTH AMERICA 250
- 11.5.1 BRAZIL 255
- 11.5.2 ARGENTINA 259
- 11.5.3 REST OF SOUTH AMERICA 263
- 11.6 MIDDLE EAST AND AFRICA 264
- 11.6.1 SAUDI ARABIA 269
- 11.6.2 SOUTH AFRICA 273
- 11.6.3 EGYPT 277
- 11.6.4 U.A.E. 281
- 11.6.5 ISRAEL 285
- 11.6.6 KUWAIT 289
- 11.6.7 OMAN 293
- 11.6.8 QATAR 297
- 11.6.9 BAHRAIN 301
- 11.6.10 REST OF MIDDLE EAST AND AFRICA 305
12 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET: COMPANY LANDSCAPE 306
- 12.1 COMPANY SHARE ANALYSIS: GLOBAL 306
- 12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 307
- 12.3 COMPANY SHARE ANALYSIS: EUROPE 308
- 12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 309
13 SWOT ANALYSIS 310
14 COMPANY PROFILE 311
- 14.1 MEDIDATA 311
- 14.1.1 COMPANY SNAPSHOT 311
- 14.1.2 REVENUE ANALYSIS 311
- 14.1.3 COMPANY SHARE ANALYSIS 312
- 14.1.4 SOLUTION PORTFOLIO 312
- 14.1.5 RECENT DEVELOPMENTS 312
- 14.2 IQVIA INC 315
- 14.2.1 COMPANY SNAPSHOT 315
- 14.2.2 REVENUE ANALYSIS 315
- 14.2.3 COMPANY SHARE ANALYSIS 316
- 14.2.4 PRODUCT PORTFOLIO 316
- 14.2.5 RECENT DEVELOPMENTS 316
- 14.3 CLARIO 318
- 14.3.1 COMPANY SNAPSHOT 318
- 14.3.2 COMPANY SHARE ANALYSIS 318
- 14.3.3 SOLUTION PORTFOLIO 319
- 14.3.4 RECENT DEVELOPMENTS 319
- 14.4 SIGNANT HEALTH 321
- 14.4.1 COMPANY SNAPSHOT 321
- 14.4.2 SOLUTION PORTFOLIO 321
- 14.4.3 RECENT DEVELOPMENTS 322
- 14.5 ARISGLOBAL 323
- 14.5.1 COMPANY SNAPSHOT 323
- 14.5.2 SOLUTION PORTFOLIO 323
- 14.5.3 RECENT DEVELOPMENTS 325
- 14.6 ASSISTEK 327
- 14.6.1 COMPANY SNAPSHOT 327
- 14.6.2 SERVICE PORTFOLIO 327
- 14.6.3 RECENT DEVELOPMENT 328
- 14.7 CASTOR 329
- 14.7.1 COMPANY SNAPSHOT 329
- 14.7.2 PRODUCT PORTFOLIO 329
- 14.7.3 RECENT DEVELOPMENTS 330
- 14.8 CLIMEDO HEALTH GMBH 331
- 14.8.1 COMPANY SNAPSHOT 331
- 14.8.2 PRODUCT PORTFOLIO 331
- 14.8.3 RECENT DEVELOPMENT 331
- 14.9 CLINCAPTURE 332
- 14.9.1 COMPANY SNAPSHOT 332
- 14.9.2 PRODUCT PORTFOLIO 332
- 14.9.3 RECENT DEVELOPMENT 332
- 14.10 CLINICAL INK 333
- 14.10.1 COMPANY SNAPSHOT 333
- 14.10.2 SOLUTION PORTFOLIO 333
- 14.10.3 RECENT DEVELOPMENTS 334
- 14.11 CLOUDBYZ 335
- 14.11.1 COMPANY SNAPSHOT 335
- 14.11.2 SOLUTION PORTFOLIO 335
- 14.11.3 RECENT DEVELOPMENTS 335
- 14.12 CRUCIAL DATA SOLUTIONS 337
- 14.12.1 COMPANY SNAPSHOT 337
- 14.12.2 SOLUTION PORTFOLIO 337
- 14.12.3 RECENT DEVELOPMENTS 337
- 14.13 EVIDENTIQ 339
- 14.13.1 COMPANY SNAPSHOT 339
- 14.13.2 PRODUCT PORTFOLIO 339
- 14.13.3 RECENT DEVELOPMENTS 340
- 14.14 KAYENTIS 341
- 14.14.1 COMPANY SNAPSHOT 341
- 14.14.2 SOLUTION PORTFOLIO 341
- 14.14.3 RECENT DEVELOPMENTS 341
- 14.15 MEDABLE INC. 343
- 14.15.1 COMPANY SNAPSHOT 343
- 14.15.2 PRODUCT PORTFOLIO 343
- 14.15.3 RECENT DEVELOPMENTS 344
- 14.16 MERATIVE 345
- 14.16.1 COMPANY SNAPSHOT 345
- 14.16.2 SOLUTION PORTFOLIO 345
- 14.16.3 RECENT DEVELOPMENTS 345
- 14.17 PATTERN HEALTH TECHNOLOGIES, INC. 347
- 14.17.1 COMPANY SNAPSHOT 347
- 14.17.2 SERVICE PORTFOLIO 347
- 14.17.3 RECENT DEVELOPMENTS 347
- 14.18 RAYLYTIC GMBH 349
- 14.18.1 COMPANY SNAPSHOT 349
- 14.18.2 SOLUTION PORTFOLIO 349
- 14.18.3 RECENT DEVELOPMENT 350
- 14.19 SUVODA LLC 351
- 14.19.1 COMPANY SNAPSHOT 351
- 14.19.2 PRODUCT PORTFOLIO 351
- 14.19.3 RECENT DEVELOPMENT 352
- 14.20 TRANSPERFECT LIFE SCIENCES 353
- 14.20.1 COMPANY SNAPSHOT 353
- 14.20.2 SOLUTION PORTFOLIO 353
- 14.20.3 RECENT DEVELOPMENT 354
- 14.21 VITALOGRAPH 355
- 14.21.1 COMPANY SNAPSHOT 355
- 14.21.2 SERVICES PORTFOLIO 355
- 14.21.3 RECENT DEVELOPMENTS 356
- 14.22 WCG CLINICAL 357
- 14.22.1 COMPANY SNAPSHOT 357
- 14.22.2 PRODUCT PORTFOLIO 357
- 14.22.3 RECENT DEVELOPMENT 357
- 14.23 YPRIME LLC. 359
- 14.23.1 COMPANY SNAPSHOT 359
- 14.23.2 SOLUTION PORTFOLIO 359
- 14.23.3 RECENT DEVELOPMENTS 360
15 QUESTIONNAIRE 362
16 RELATED REPORTS 365